Zavod Medsintez

Health

Russian-Pakistani $80M Insulin Venture Enters Critical Accountability Phase as DRAP Issues Strict Deadline

ISLAMABAD/MOSCOW — A $80 million Russian-Pakistani pharmaceutical venture aimed at ending Pakistan’s dependence on imported insulin has entered a critical…